AbbVie Inc. (ABBV) Second Phase 3 Induction Study Confirms Upadacitinib (RINVOQ®) Improved Clinical and Endoscopic Outcomes

Second Phase 3 Induction Study Confirms Upadacitinib (RINVOQ®) Improved Clinical and Endoscopic…

AbbVie Inc. (ABBV) Provincial Reimbursement for VENCLEXTA® (venetoclax) with Obinutuzumab for Patients

AbbVie Announces Provincial Reimbursement for VENCLEXTA® (venetoclax) with Obinutuzumab for Patients with…

Jushi Holdings Inc. (JUSHF) Announces Participation in Upcoming Webinar and Conference

Jushi Holdings Inc. Announces Participation in Upcoming Webinar and Conference Jushi Holdings…

Trulieve Cannabis Corp. (TCNNF) Announces Exclusive Partnership with Khalifa Kush

Trulieve Announces Exclusive Partnership with Khalifa Kush Trulieve Cannabis Corp. (CSE: TRUL)…